Bayer's finerenone hits targets in diabetes/kidney disease trial
admin 10th July 2020 Uncategorised 0The drug hit primary and secondary goals of the Phase III FIDELIO-DKD renal outcomes study
More: Bayer's finerenone hits targets in diabetes/kidney disease trial
Source: News